You are currently viewing a beta version of our website. If you spot anything unusual, kindly let us know.
Altmetrics
Downloads
90
Views
37
Comments
0
A peer-reviewed article of this preprint also exists.
This version is not peer-reviewed
Variable | Question |
---|---|
Hypothesized percentage of patients with concomitant chronic pain and GAD | What is the PERCENTAGE of patients with persistent pain who may have an attitude of extreme concern and a general pessimistic view about their future along with sleep disturbances and muscle tension? |
Hypothesized percentage of treatment withdrawal in patients with concomitant chronic pain and GAD | What is the PERCENTAGE of patients, with the symptoms of the previous question, that you think can early withdraw an effective therapeutic program? |
Hypothesized percentage of patients with concomitant chronic pain and depressive disorders | What is the PERCENTAGE of patients with persistent pain who may have depressed mood for at least two weeks possibly together with a general reduction in interest, difficulties of concentration, sleep disturbances, decreased appetite, reduced energy, feelings of guilt and social dysfunction? |
Hypothesized percentage of treatment withdrawal in patients with concomitant chronic pain and depressive disorders | What is the PERCENTAGE of patients, with the symptoms of the previous question that you think can early withdraw an effective therapeutic program? |
Referred percentage of patients with persistent pain treated by the physiotherapists | What is the PERCENTAGE of patients with persistent pain episodes who you treat? |
Utility of mental health screening in patients suffering from chronic pain | Do you think that mental health screening can be useful to improve prognosis and to reduce healthcare costs in patients suffering from chronic pain? |
Ability to interact with patients affected by mood and anxiety disorders | How much do you feel confident in interact with patients affected by anxiety disorders or depression? |
Ability to interact with patients with chronic pain and comorbid mood or anxiety disorders | How much do you feel confident to interact with patients affected by chronic pain and comorbid anxiety or depressive disorders? |
Presence of a trusted professional to refer patients to after screening for anxiety or depressive | Do you have a trusted professional to refer patients after screening for anxiety disorders and depression? |
Percentage of patients with chronic pain who are believed to accept the indication to consult a mental health professional | What is the expected PERCENTAGE of patients that you think will accept the referral to a mental health professional? |
Percentage of patients with chronic pain who are believed to withdraw physiotherapy after visit with a mental health professional | What is the expected PERCENTAGE of patients that you think will drop out of physiotherapy after consulting a mental health professional? |
Percentage of patients with chronic pain and comorbid mood/anxiety disorders who are believed to benefit from pharmacotherapy | What is the PERCENTAGE of patients with symptoms of anxiety and /or depression who can benefit from a pharmacological approach in your opinion? |
Percentage of patients with chronic pain and comorbid mood/anxiety disorders who are believed to benefit from psychotherapy | What is PERCENTAGE of patients with symptoms of anxiety and / or depression who can benefit from a psychotherapeutic approach in your opinion? |
Knowledge of side effects of pharmacotherapy | How much do you know about the side effects of the medications available to treat symptoms of anxiety and depression? Rate on a scale from 0 (no knowledge) to 100 (full knowledge). |
Degree of agreement with the statement: "psychopharmacological therapy negatively affects motor performance” | Could you express your degree of agreement regarding this statement: “psychopharmacological therapy negatively affects motor performance”. Rate on a scale from 0 (no agreement) to 100 (complete agreement). |
Participation in psychiatry training events | Did you attend psychiatric educational or training courses? |
Importance for physiotherapists to be trained in the recognition of anxiety and depressive symptoms | How much the identification of anxiety and depression symptoms is relevant for a physiotherapist? Rate on a scale from 0 (totally no) to 100 (totally yes). |
Use of rating scales to assess anxiety and depressive symptoms in patients with chronic pain | Did you ever screen your patients with chronic pain by rating scales assessing depression and anxiety? |
Observation of the administration of rating scales for anxiety and depressive symptoms | Have you never assisted to the administration of rating scales to assess the presence of anxiety and depression? |
Attendance of training courses to administer psychiatric rating scales | Have you never attended training courses to administer psychiatric rating scales? |
Utility of more mental health training for the physiotherapists | How much can a training on mental health be useful for your profession? Rate on a scale from 0 (totally no) to 100 (totally yes). |
Variable | Total sample N=327 | Males N=163 | Females N =164 | p | |
---|---|---|---|---|---|
Age | 40.22 (± 10.04) | 39.17 (± 9.97) | 41.26 (± 10.03) | 0.06 | |
Years of work experience |
<5 years | 33 (10.1%) | 17 (10.4%) | 16 (9.8%) | 0.08 |
from 5 to 10 years | 81 (24.8%) | 50 (30.7%) | 31 (18.9%) | ||
from 10 to 20 years | 113 (34.6 %) | 53 (32.5%) | 60 (36.6%) | ||
>20 years | 100 (30.5%) | 43 (26.4%) | 57 (34.7%) | ||
Italian area Missing=2 |
North-west | 109 (33.5%) | 50 (31.1%) | 59 (36.0%) | 0.14 |
North-east | 119 (36.6%) | 55 (34.2%) | 64 (39.0%) | ||
Central | 60 (18.5%) | 37 (22.9%) | 23 (14.0%) | ||
South | 25 (7.7%) | 15 (9.3%) | 10 (6.1%) | ||
Islands | 12 (3.7%) | 4 (2.5%) | 8 (4.9%) | ||
Work setting |
Private | 124 (37.9%) | 38 (23.3%) | 86 (52.4%) | <0.01 |
Others | 203 (62.1%) | 125 (76.7%) | 78 (47.6%) | ||
Work area (size population) Missing=1 |
>500000 | 55 (16.6%) | 31(19.0%) | 23 (14.1%) | 0.65 |
>100000 <500000 | 74 (22.7%) | 37 (22.7%) | 37 (22.7%) | ||
15000-100000 | 84 (25.7%) | 39 (23.9%) | 45 (27.6%) | ||
<15000 | 114 (35.0%) | 56 (34.4%) | 58 (35.6%) | ||
Main area of physiotherapy interest Missing=1 |
Musculoskeletal disorders | 155 (47.5%) | 58 (35.6%) | 97 (59.5%) | <0.01 |
Others | 171 (52.5%) | 105 (64.4%) | 66 (40.5%) | ||
Medical comorbidity that is considered to be more associated with chronic pain Missing=3 |
Diabetes | 124 (38.3%) | 55 (33.7%) | 69 (42.9%) | 0.15 |
Cardiovascular diseases | 78 (24.1%) | 44 (27.0%) | 34 (21.1%) | ||
Respiratory diseases | 19 (5.8%) | 7 (4.3%) | 12 (7.5%) | ||
Mental disorders | 103 (31.8%) | 57 (35.0%) | 46 (28.5%) | ||
Hypothesized percentage of patients with concomitant chronic pain and GAD Missing=10 |
61.27 ((± 23.31) | 59.92 (± 22.78) | 62.62 (± 23.83) | 0.30 | |
Hypothesized percentage of treatment withdrawal in patients with concomitant chronic pain and GAD Missing=13 |
40.36 (± 24.30) | 43.73 (± 24.17) | 37.03 (± 24.04) | 0.01 | |
Hypothesized percentage of patients with concomitant chronic pain and depressive disorders Missing=11 |
57.26 (± 26.34) | 58.03 (± 25.40) | 56.51 (± 27.28) | 0.61 | |
Hypothesized percentage of treatment withdrawal in patients with concomitant chronic pain and depressive disorders Missing=14 |
43.75 (± 26.43) | 46.39 (± 26.32) | 41.13 (± 26.36) | 0.08 | |
Referred percentage of patients with persistent pain treated by the physiotherapists Missing=6 |
33.47 (± 25.34) | 34.07 (± 25.29) | 32.88 (± 25.45) | 0.67 | |
Percentage of patients with chronic pain who are believed to accept the indication to consult a mental health professional Missing=11 |
30.22 (± 21.81) | 31.90 (± 21.22) | 28.51 (± 22.34) | 0.17 | |
Percentage of patients with chronic pain who are believed to withdraw physiotherapy after visit with a mental health professional Missing=14 |
24.84 (± 22.56) | 28.35 (± 23.29) | 21.30 (± 21.29) | 0.01 | |
Percentage of patients with chronic pain and comorbid mood/anxiety disorders who are believed to benefit from pharmacotherapy Missing=23 |
42.81 (± 25.14) | 45.07 (± 25.20) | 40.55 (± 24.95) | 0.12 | |
Percentage of patients with chronic pain and comorbid mood/anxiety disorders who are believed to benefit from psychotherapy Missing=16 |
76.39 (± 22.47) | 75.45 (± 19.52) | 77.33 (± 25.08) | 0.46 | |
Knowledge of side effects of pharmacotherapy* Missing=7 |
37.15 (± 28.28) | 38.68 (± 28.79) | 35.63 (± 27.76) | 0.34 | |
Degree of agreement with the statement: "psychopharmacological therapy negatively affects motor performance"* Missing=17 |
46.77 (± 28.91) | 51.45 (± 29.30) | 42.03 (± 27.82) | <0.01 | |
Participation in psychiatry training events Missing=2 |
No | 250 (76.9%) | 124 (76.5%) | 126 (77.3%) | 0.87 |
Yes | 75 (23.1%) | 38 (23.5%) | 37 (22.7%) | ||
Importance for physiotherapists to be trained in the recognition of anxiety and depressive symptoms* Missing=3 |
87.55 (± 18.13) | 84.91 (± 19.26) | 90.20 (± 16.57) | 0.01 | |
Use of rating scales to assess anxiety and depressive symptoms in patients with chronic pain Missing=2 |
No | 272 (83.7%) | 131 (80.9%) | 141 (86.5%) | 0.17 |
Yes | 53 (16.3%) | 31 (19.1%) | 22 (13.5%) | ||
Observation of the administration of rating scales for anxiety and depressive symptoms Missing=2 |
No | 232 (71.4%) | 120 (74.1%) | 112 (68.7%) | 0.29 |
Yes | 93 (28.6%) | 42 (25.9%) | 51 (31.3%) | ||
Attendance of training courses to administer psychiatric rating scales Missing=3 |
No | 298 (92.0%) | 149 (92.0%) | 149 (92.0%) | 1.00 |
Yes | 26 (8.0%) | 13 (8.0%) | 13 (8.0%) | ||
Utility of more mental health training for the physiotherapists* |
81.79 (± 22.03) | 78.33 (± 23.55) | 85.26 (± 19.88) | 0.01 | |
Ability to interact with patients affected by mood and anxiety disorders |
Perfectly comfortable | 37 (11.3%) | 26 (16.0%) | 11 (6.7%) | <0.01 |
Usually comfortable | 158 (48.3%) | 76 (46.6%) | 82 (50.0%) | ||
Neutral | 22 (6.7%) | 12 (7.4%) | 10 (6.1%) | ||
Sometimes uncomfortable | 86 (26.3%) | 32 (19.6%) | 54 (32.9%) | ||
Often uncomfortable | 24 (7.4%) | 17 (10.4%) | 7 (4.3%) | ||
Ability to interact with patients with chronic pain and comorbid mood or anxiety disorders |
Perfectly comfortable | 33 (10.1%) | 24 (14.7%) | 9 (5.5%) | <0.01 |
Usually comfortable | 141 (43.1%) | 68 (41.7%) | 73 (44.5%) | ||
Neutral | 36 (11.1%) | 23 (14.2%) | 13 (7.9%) | ||
Sometimes uncomfortable | 92 (28.1%) | 32 (19.6%) | 60 (36.6%) | ||
Often uncomfortable | 25 (7.6%) | 16 (9.8%) | 9 (5.5%) | ||
Utility of mental health screening in patients suffering from chronic pain Missing=2 |
No, I am just interested in my practice | 1 (0.3%) | 1 (0.6%) | 0 (0.0%) | 0.55 |
No, it is not cost-effective | 11 (3.4%) | 7 (4.3%) | 4 (2.5%) | ||
Yes, it should be done for selected patients | 230 (70.8%) | 115 (71.0%) | 115 (70.5%) | ||
Yes, it should be done for all patients | 83 (25.5%) | 39 (24.1%) | 44 (27.0%) | ||
Presence of a trusted professional to refer patients to after screening for anxiety or depressive symptoms | No | 76 (46.6%) | 87 (53.0%) | 163 (49.8%) | 0.25 |
Yes | 87 (53.4%) | 77 (47.0%) | 164 (50.2%) |
Variables | B | SE | p | OR | 95% CI |
---|---|---|---|---|---|
Hypothesized percentage of treatment withdrawal in patients with concomitant chronic pain and GAD | -0.011 | 0.006 | 0.050 | 0.989 | 0.977-0.999 |
Percentage of patients with chronic pain who are believed to withdraw physiotherapy after visit with a mental health professional | -0.010 | 0.007 | 0.128 | 0.990 | 0.977-1.003 |
Degree of agreement with the statement: "psychopharmacological therapy negatively affects motor performance"* | -0.009 | 0.005 | 0.085 | 0.991 | 0.981-1.001 |
Importance for physiotherapists to be trained in the recognition of anxiety and depressive symptoms* | 0.017 | 0.009 | 0.080 | 1.017 | 0.998-1.036 |
Utility of more mental health training for the physiotherapists* | 0.009 | 0.008 | 0.268 | 1.009 | 0.993-1.024 |
Work setting (private versus others) | -0.775 | 0.319 | 0.015 | 0.461 | 0.246-0.860 |
Musculoskeletal disorders as the main area of interest (Yes versus No) | -0.431 | 0.304 | 0.157 | 0.650 | 0.358-1.180 |
Ability to interact with patients affected by mood and anxiety disorders | NA | NA | 0.442 | NA | NA |
Ability to interact with patients with chronic pain and comorbid mood or anxiety disorders | NA | NA | 0.076 | NA | NA |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
Submitted:
08 January 2024
Posted:
09 January 2024
You are already at the latest version
A peer-reviewed article of this preprint also exists.
This version is not peer-reviewed
Submitted:
08 January 2024
Posted:
09 January 2024
You are already at the latest version
Variable | Question |
---|---|
Hypothesized percentage of patients with concomitant chronic pain and GAD | What is the PERCENTAGE of patients with persistent pain who may have an attitude of extreme concern and a general pessimistic view about their future along with sleep disturbances and muscle tension? |
Hypothesized percentage of treatment withdrawal in patients with concomitant chronic pain and GAD | What is the PERCENTAGE of patients, with the symptoms of the previous question, that you think can early withdraw an effective therapeutic program? |
Hypothesized percentage of patients with concomitant chronic pain and depressive disorders | What is the PERCENTAGE of patients with persistent pain who may have depressed mood for at least two weeks possibly together with a general reduction in interest, difficulties of concentration, sleep disturbances, decreased appetite, reduced energy, feelings of guilt and social dysfunction? |
Hypothesized percentage of treatment withdrawal in patients with concomitant chronic pain and depressive disorders | What is the PERCENTAGE of patients, with the symptoms of the previous question that you think can early withdraw an effective therapeutic program? |
Referred percentage of patients with persistent pain treated by the physiotherapists | What is the PERCENTAGE of patients with persistent pain episodes who you treat? |
Utility of mental health screening in patients suffering from chronic pain | Do you think that mental health screening can be useful to improve prognosis and to reduce healthcare costs in patients suffering from chronic pain? |
Ability to interact with patients affected by mood and anxiety disorders | How much do you feel confident in interact with patients affected by anxiety disorders or depression? |
Ability to interact with patients with chronic pain and comorbid mood or anxiety disorders | How much do you feel confident to interact with patients affected by chronic pain and comorbid anxiety or depressive disorders? |
Presence of a trusted professional to refer patients to after screening for anxiety or depressive | Do you have a trusted professional to refer patients after screening for anxiety disorders and depression? |
Percentage of patients with chronic pain who are believed to accept the indication to consult a mental health professional | What is the expected PERCENTAGE of patients that you think will accept the referral to a mental health professional? |
Percentage of patients with chronic pain who are believed to withdraw physiotherapy after visit with a mental health professional | What is the expected PERCENTAGE of patients that you think will drop out of physiotherapy after consulting a mental health professional? |
Percentage of patients with chronic pain and comorbid mood/anxiety disorders who are believed to benefit from pharmacotherapy | What is the PERCENTAGE of patients with symptoms of anxiety and /or depression who can benefit from a pharmacological approach in your opinion? |
Percentage of patients with chronic pain and comorbid mood/anxiety disorders who are believed to benefit from psychotherapy | What is PERCENTAGE of patients with symptoms of anxiety and / or depression who can benefit from a psychotherapeutic approach in your opinion? |
Knowledge of side effects of pharmacotherapy | How much do you know about the side effects of the medications available to treat symptoms of anxiety and depression? Rate on a scale from 0 (no knowledge) to 100 (full knowledge). |
Degree of agreement with the statement: "psychopharmacological therapy negatively affects motor performance” | Could you express your degree of agreement regarding this statement: “psychopharmacological therapy negatively affects motor performance”. Rate on a scale from 0 (no agreement) to 100 (complete agreement). |
Participation in psychiatry training events | Did you attend psychiatric educational or training courses? |
Importance for physiotherapists to be trained in the recognition of anxiety and depressive symptoms | How much the identification of anxiety and depression symptoms is relevant for a physiotherapist? Rate on a scale from 0 (totally no) to 100 (totally yes). |
Use of rating scales to assess anxiety and depressive symptoms in patients with chronic pain | Did you ever screen your patients with chronic pain by rating scales assessing depression and anxiety? |
Observation of the administration of rating scales for anxiety and depressive symptoms | Have you never assisted to the administration of rating scales to assess the presence of anxiety and depression? |
Attendance of training courses to administer psychiatric rating scales | Have you never attended training courses to administer psychiatric rating scales? |
Utility of more mental health training for the physiotherapists | How much can a training on mental health be useful for your profession? Rate on a scale from 0 (totally no) to 100 (totally yes). |
Variable | Total sample N=327 | Males N=163 | Females N =164 | p | |
---|---|---|---|---|---|
Age | 40.22 (± 10.04) | 39.17 (± 9.97) | 41.26 (± 10.03) | 0.06 | |
Years of work experience |
<5 years | 33 (10.1%) | 17 (10.4%) | 16 (9.8%) | 0.08 |
from 5 to 10 years | 81 (24.8%) | 50 (30.7%) | 31 (18.9%) | ||
from 10 to 20 years | 113 (34.6 %) | 53 (32.5%) | 60 (36.6%) | ||
>20 years | 100 (30.5%) | 43 (26.4%) | 57 (34.7%) | ||
Italian area Missing=2 |
North-west | 109 (33.5%) | 50 (31.1%) | 59 (36.0%) | 0.14 |
North-east | 119 (36.6%) | 55 (34.2%) | 64 (39.0%) | ||
Central | 60 (18.5%) | 37 (22.9%) | 23 (14.0%) | ||
South | 25 (7.7%) | 15 (9.3%) | 10 (6.1%) | ||
Islands | 12 (3.7%) | 4 (2.5%) | 8 (4.9%) | ||
Work setting |
Private | 124 (37.9%) | 38 (23.3%) | 86 (52.4%) | <0.01 |
Others | 203 (62.1%) | 125 (76.7%) | 78 (47.6%) | ||
Work area (size population) Missing=1 |
>500000 | 55 (16.6%) | 31(19.0%) | 23 (14.1%) | 0.65 |
>100000 <500000 | 74 (22.7%) | 37 (22.7%) | 37 (22.7%) | ||
15000-100000 | 84 (25.7%) | 39 (23.9%) | 45 (27.6%) | ||
<15000 | 114 (35.0%) | 56 (34.4%) | 58 (35.6%) | ||
Main area of physiotherapy interest Missing=1 |
Musculoskeletal disorders | 155 (47.5%) | 58 (35.6%) | 97 (59.5%) | <0.01 |
Others | 171 (52.5%) | 105 (64.4%) | 66 (40.5%) | ||
Medical comorbidity that is considered to be more associated with chronic pain Missing=3 |
Diabetes | 124 (38.3%) | 55 (33.7%) | 69 (42.9%) | 0.15 |
Cardiovascular diseases | 78 (24.1%) | 44 (27.0%) | 34 (21.1%) | ||
Respiratory diseases | 19 (5.8%) | 7 (4.3%) | 12 (7.5%) | ||
Mental disorders | 103 (31.8%) | 57 (35.0%) | 46 (28.5%) | ||
Hypothesized percentage of patients with concomitant chronic pain and GAD Missing=10 |
61.27 ((± 23.31) | 59.92 (± 22.78) | 62.62 (± 23.83) | 0.30 | |
Hypothesized percentage of treatment withdrawal in patients with concomitant chronic pain and GAD Missing=13 |
40.36 (± 24.30) | 43.73 (± 24.17) | 37.03 (± 24.04) | 0.01 | |
Hypothesized percentage of patients with concomitant chronic pain and depressive disorders Missing=11 |
57.26 (± 26.34) | 58.03 (± 25.40) | 56.51 (± 27.28) | 0.61 | |
Hypothesized percentage of treatment withdrawal in patients with concomitant chronic pain and depressive disorders Missing=14 |
43.75 (± 26.43) | 46.39 (± 26.32) | 41.13 (± 26.36) | 0.08 | |
Referred percentage of patients with persistent pain treated by the physiotherapists Missing=6 |
33.47 (± 25.34) | 34.07 (± 25.29) | 32.88 (± 25.45) | 0.67 | |
Percentage of patients with chronic pain who are believed to accept the indication to consult a mental health professional Missing=11 |
30.22 (± 21.81) | 31.90 (± 21.22) | 28.51 (± 22.34) | 0.17 | |
Percentage of patients with chronic pain who are believed to withdraw physiotherapy after visit with a mental health professional Missing=14 |
24.84 (± 22.56) | 28.35 (± 23.29) | 21.30 (± 21.29) | 0.01 | |
Percentage of patients with chronic pain and comorbid mood/anxiety disorders who are believed to benefit from pharmacotherapy Missing=23 |
42.81 (± 25.14) | 45.07 (± 25.20) | 40.55 (± 24.95) | 0.12 | |
Percentage of patients with chronic pain and comorbid mood/anxiety disorders who are believed to benefit from psychotherapy Missing=16 |
76.39 (± 22.47) | 75.45 (± 19.52) | 77.33 (± 25.08) | 0.46 | |
Knowledge of side effects of pharmacotherapy* Missing=7 |
37.15 (± 28.28) | 38.68 (± 28.79) | 35.63 (± 27.76) | 0.34 | |
Degree of agreement with the statement: "psychopharmacological therapy negatively affects motor performance"* Missing=17 |
46.77 (± 28.91) | 51.45 (± 29.30) | 42.03 (± 27.82) | <0.01 | |
Participation in psychiatry training events Missing=2 |
No | 250 (76.9%) | 124 (76.5%) | 126 (77.3%) | 0.87 |
Yes | 75 (23.1%) | 38 (23.5%) | 37 (22.7%) | ||
Importance for physiotherapists to be trained in the recognition of anxiety and depressive symptoms* Missing=3 |
87.55 (± 18.13) | 84.91 (± 19.26) | 90.20 (± 16.57) | 0.01 | |
Use of rating scales to assess anxiety and depressive symptoms in patients with chronic pain Missing=2 |
No | 272 (83.7%) | 131 (80.9%) | 141 (86.5%) | 0.17 |
Yes | 53 (16.3%) | 31 (19.1%) | 22 (13.5%) | ||
Observation of the administration of rating scales for anxiety and depressive symptoms Missing=2 |
No | 232 (71.4%) | 120 (74.1%) | 112 (68.7%) | 0.29 |
Yes | 93 (28.6%) | 42 (25.9%) | 51 (31.3%) | ||
Attendance of training courses to administer psychiatric rating scales Missing=3 |
No | 298 (92.0%) | 149 (92.0%) | 149 (92.0%) | 1.00 |
Yes | 26 (8.0%) | 13 (8.0%) | 13 (8.0%) | ||
Utility of more mental health training for the physiotherapists* |
81.79 (± 22.03) | 78.33 (± 23.55) | 85.26 (± 19.88) | 0.01 | |
Ability to interact with patients affected by mood and anxiety disorders |
Perfectly comfortable | 37 (11.3%) | 26 (16.0%) | 11 (6.7%) | <0.01 |
Usually comfortable | 158 (48.3%) | 76 (46.6%) | 82 (50.0%) | ||
Neutral | 22 (6.7%) | 12 (7.4%) | 10 (6.1%) | ||
Sometimes uncomfortable | 86 (26.3%) | 32 (19.6%) | 54 (32.9%) | ||
Often uncomfortable | 24 (7.4%) | 17 (10.4%) | 7 (4.3%) | ||
Ability to interact with patients with chronic pain and comorbid mood or anxiety disorders |
Perfectly comfortable | 33 (10.1%) | 24 (14.7%) | 9 (5.5%) | <0.01 |
Usually comfortable | 141 (43.1%) | 68 (41.7%) | 73 (44.5%) | ||
Neutral | 36 (11.1%) | 23 (14.2%) | 13 (7.9%) | ||
Sometimes uncomfortable | 92 (28.1%) | 32 (19.6%) | 60 (36.6%) | ||
Often uncomfortable | 25 (7.6%) | 16 (9.8%) | 9 (5.5%) | ||
Utility of mental health screening in patients suffering from chronic pain Missing=2 |
No, I am just interested in my practice | 1 (0.3%) | 1 (0.6%) | 0 (0.0%) | 0.55 |
No, it is not cost-effective | 11 (3.4%) | 7 (4.3%) | 4 (2.5%) | ||
Yes, it should be done for selected patients | 230 (70.8%) | 115 (71.0%) | 115 (70.5%) | ||
Yes, it should be done for all patients | 83 (25.5%) | 39 (24.1%) | 44 (27.0%) | ||
Presence of a trusted professional to refer patients to after screening for anxiety or depressive symptoms | No | 76 (46.6%) | 87 (53.0%) | 163 (49.8%) | 0.25 |
Yes | 87 (53.4%) | 77 (47.0%) | 164 (50.2%) |
Variables | B | SE | p | OR | 95% CI |
---|---|---|---|---|---|
Hypothesized percentage of treatment withdrawal in patients with concomitant chronic pain and GAD | -0.011 | 0.006 | 0.050 | 0.989 | 0.977-0.999 |
Percentage of patients with chronic pain who are believed to withdraw physiotherapy after visit with a mental health professional | -0.010 | 0.007 | 0.128 | 0.990 | 0.977-1.003 |
Degree of agreement with the statement: "psychopharmacological therapy negatively affects motor performance"* | -0.009 | 0.005 | 0.085 | 0.991 | 0.981-1.001 |
Importance for physiotherapists to be trained in the recognition of anxiety and depressive symptoms* | 0.017 | 0.009 | 0.080 | 1.017 | 0.998-1.036 |
Utility of more mental health training for the physiotherapists* | 0.009 | 0.008 | 0.268 | 1.009 | 0.993-1.024 |
Work setting (private versus others) | -0.775 | 0.319 | 0.015 | 0.461 | 0.246-0.860 |
Musculoskeletal disorders as the main area of interest (Yes versus No) | -0.431 | 0.304 | 0.157 | 0.650 | 0.358-1.180 |
Ability to interact with patients affected by mood and anxiety disorders | NA | NA | 0.442 | NA | NA |
Ability to interact with patients with chronic pain and comorbid mood or anxiety disorders | NA | NA | 0.076 | NA | NA |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
Dariusz Kosson
et al.
IJERPH,
2019
Dariusz Kosson
et al.
IJERPH,
2018
© 2024 MDPI (Basel, Switzerland) unless otherwise stated